Jonathan B. Gubbay

11.7k total citations · 5 hit papers
172 papers, 6.9k citations indexed

About

Jonathan B. Gubbay is a scholar working on Epidemiology, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Jonathan B. Gubbay has authored 172 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Epidemiology, 66 papers in Infectious Diseases and 21 papers in Modeling and Simulation. Recurrent topics in Jonathan B. Gubbay's work include Respiratory viral infections research (91 papers), Influenza Virus Research Studies (82 papers) and Pneumonia and Respiratory Infections (27 papers). Jonathan B. Gubbay is often cited by papers focused on Respiratory viral infections research (91 papers), Influenza Virus Research Studies (82 papers) and Pneumonia and Respiratory Infections (27 papers). Jonathan B. Gubbay collaborates with scholars based in Canada, United States and United Kingdom. Jonathan B. Gubbay's co-authors include Samira Mubareka, Alireza Eshaghi, Matthew Osborne, Ayden Malekjahani, Pranav Kadhiresan, Warren C. W. Chan, Buddhisha Udugama, Hongmin Chen, H Kozłowski and Anne‐Luise Winter and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Communications.

In The Last Decade

Jonathan B. Gubbay

169 papers receiving 6.8k citations

Hit Papers

Diagnosing COVID-19: The ... 2018 2026 2020 2023 2020 2018 2022 2022 2021 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan B. Gubbay Canada 37 3.8k 3.4k 967 744 660 172 6.9k
Joanna Ellis United Kingdom 38 3.3k 0.9× 1.7k 0.5× 573 0.6× 208 0.3× 488 0.7× 115 4.8k
Cheryl Cohen South Africa 43 4.4k 1.2× 3.1k 0.9× 392 0.4× 181 0.2× 932 1.4× 253 7.7k
Nathalie Bastien Canada 43 3.4k 0.9× 2.6k 0.8× 773 0.8× 222 0.3× 254 0.4× 104 5.5k
Alexander L. Greninger United States 49 2.7k 0.7× 6.1k 1.8× 2.1k 2.2× 762 1.0× 144 0.2× 277 10.6k
Kwok Hung Chan Hong Kong 51 3.2k 0.9× 4.9k 1.5× 867 0.9× 563 0.8× 145 0.2× 135 9.5k
Samira Mubareka Canada 31 2.4k 0.6× 2.6k 0.8× 952 1.0× 970 1.3× 149 0.2× 127 6.1k
Ravindra K. Gupta United Kingdom 36 1.7k 0.4× 5.0k 1.5× 1.5k 1.6× 249 0.3× 249 0.4× 171 8.0k
Mel Krajden Canada 57 8.4k 2.2× 3.5k 1.0× 871 0.9× 131 0.2× 560 0.8× 367 11.8k
Ping‐Ing Lee Taiwan 43 3.0k 0.8× 2.8k 0.8× 521 0.5× 168 0.2× 283 0.4× 238 7.0k
Yong Poovorawan Thailand 54 8.2k 2.1× 6.0k 1.8× 1.8k 1.8× 449 0.6× 537 0.8× 763 15.4k

Countries citing papers authored by Jonathan B. Gubbay

Since Specialization
Citations

This map shows the geographic impact of Jonathan B. Gubbay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan B. Gubbay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan B. Gubbay more than expected).

Fields of papers citing papers by Jonathan B. Gubbay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan B. Gubbay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan B. Gubbay. The network helps show where Jonathan B. Gubbay may publish in the future.

Co-authorship network of co-authors of Jonathan B. Gubbay

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan B. Gubbay. A scholar is included among the top collaborators of Jonathan B. Gubbay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan B. Gubbay. Jonathan B. Gubbay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buchan, Sarah A., Samantha S. M. Drover, Melissa K. Andrew, et al.. (2025). Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017–2019. The Journal of Infectious Diseases. 232(5). e799–e810.
2.
Caza, Mélissa, Jonathan B. Gubbay, David A. Goldfarb, et al.. (2024). Investigation of suspected false positive norovirus results on a syndromic gastrointestinal multiplex molecular panel. Journal of Clinical Virology. 175. 105732–105732. 1 indexed citations
3.
Chung, Hannah, Michael A. Campitelli, Sarah A. Buchan, et al.. (2023). Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults. Clinical Infectious Diseases. 77(2). 303–311. 4 indexed citations
4.
Duvvuri, Venkata R., Joseph T. Hicks, Lambodhar Damodaran, et al.. (2023). Comparing the transmission potential from sequence and surveillance data of 2009 North American influenza pandemic waves. Infectious Disease Modelling. 8(1). 240–252. 1 indexed citations
5.
Lee, Nelson, Lena Nguyen, Peter C. Austin, et al.. (2023). Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults. Clinical Infectious Diseases. 78(5). 1372–1382. 4 indexed citations
6.
Jorgensen, Sarah C J, Deshayne B. Fell, Peter C. Austin, et al.. (2023). Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study. BMJ. 380. e074035–e074035. 26 indexed citations
7.
Patel, Hetal, et al.. (2023). COVID-19 farm outbreaks in Ontario, January - December 2020. Canada Communicable Disease Report. 49(5). 206–212.
8.
Nasreen, Sharifa, Hannah Chung, Siyi He, et al.. (2022). Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nature Microbiology. 7(3). 379–385. 170 indexed citations breakdown →
9.
Guthrie, Jennifer L., Kirby Cronin, Adriana Peci, et al.. (2021). Characteristics of SARS-CoV-2 testing for rapid diagnosis of COVID-19 during the initial stages of a global pandemic. PLoS ONE. 16(7). e0253941–e0253941. 5 indexed citations
10.
Luinstra, Kathy, et al.. (2020). Paediatric critical illness associated with respiratory infection: a single-centre, retrospective cohort study. BMJ Paediatrics Open. 4(1). e000640–e000640. 2 indexed citations
11.
Wilson, Sarah E., Laura C. Rosella, Jun Wang, et al.. (2019). Equity and impact: Ontario’s infant rotavirus immunization program five years following implementation. A population-based cohort study. Vaccine. 37(17). 2408–2414. 7 indexed citations
12.
Popov, Jelena, et al.. (2019). Haemophilus parainfluenza bacteremia post-ERCP and cholecystectomy in a pediatric patient: A case report. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 4(3). 182–186. 2 indexed citations
13.
Kwong, Jeffrey C., Kevin L. Schwartz, Michael A. Campitelli, et al.. (2018). Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. New England Journal of Medicine. 378(4). 345–353. 773 indexed citations breakdown →
14.
Rahman, Mohammed Ziaur, Mariya Kibtiya Sumiya, Lisa G. Pell, et al.. (2018). Genetic characterization of human metapneumovirus identified through community and facility‐based surveillance of infants in Dhaka, Bangladesh. Journal of Medical Virology. 91(4). 549–554. 8 indexed citations
15.
Schwartz, Kevin L., Tiffany Chan, Kellie E. Murphy, et al.. (2018). Zika virus infection in a pregnant Canadian traveler with congenital fetal malformations noted by ultrasonography at 14-weeks gestation. Tropical Diseases Travel Medicine and Vaccines. 4(1). 2–2. 3 indexed citations
16.
Duvvuri, Venkata R., Andrea Granados, Paul Rosenfeld, et al.. (2015). Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics. Scientific Reports. 5(1). 14268–14268. 105 indexed citations
17.
Duvvuri, Venkata R., et al.. (2014). Human metapneumovirus prevalence and molecular epidemiology in respiratory outbreaks in Ontario, Canada. Journal of Medical Virology. 87(2). 269–274. 20 indexed citations
18.
Kwong, Jeffrey C., Michael A. Campitelli, Jonathan B. Gubbay, et al.. (2013). Vaccine Effectiveness Against Laboratory-Confirmed Influenza Hospitalizations Among Elderly Adults During the 2010-2011 Season. Clinical Infectious Diseases. 57(6). 820–827. 48 indexed citations
19.
Eshaghi, Alireza, Venkata R. Duvvuri, Rachel Lai, et al.. (2012). Genetic Variability of Human Respiratory Syncytial Virus A Strains Circulating in Ontario: A Novel Genotype with a 72 Nucleotide G Gene Duplication. PLoS ONE. 7(3). e32807–e32807. 266 indexed citations
20.
Gubbay, Jonathan B.. (2008). Impact of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) on Invasive Pneumococcal Disease (IPD) in Children in Toronto and Peel Regions, Ontario, Canada. 46th Annual Meeting. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026